Peripheral artery disease and outcomes after myocardial infarction: An individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT

被引:46
作者
Inglis, Sally C. [1 ,2 ,3 ]
Bebchuk, Judith [4 ]
Al-Suhaim, Sultan A. [1 ]
Case, Jessica [4 ]
Pfeffer, Marc A. [5 ]
Solomon, Scott D. [5 ]
Hou, Yingxin [4 ]
Pitt, Bertram [6 ]
Dargie, Henry J. [7 ]
Ford, Ian [8 ]
Kjekshus, John [9 ]
Zannad, Faiez [10 ,11 ]
Dickstein, Kenneth [12 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[3] Univ Technol Sydney, Fac Nursing Midwifery & Hlth, Sydney, NSW 2007, Australia
[4] Stat Collaborat Inc, Washington, DC USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[6] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[7] Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland
[8] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8TA, Lanark, Scotland
[9] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway
[10] Univ Lorraine, INSERM, CIC9501, F-54500 Vandoeuvre Les Nancy, France
[11] Univ Lorraine, CHU Nancy, Hypertens & Heart Failure Unit, Inst Lorrain Coeur & Vaisseaux,U961, F-54500 Vandoeuvre Les Nancy, France
[12] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Peripheral vascular disease; Myocardial infarction; Heart failure; Prognosis; LEFT-VENTRICULAR DYSFUNCTION; ACUTE CORONARY SYNDROMES; RANDOMIZED TRIAL; HEART-FAILURE; RISK-FACTOR; MORTALITY; PREVALENCE; CAPTOPRIL; DESIGN; EPLERENONE;
D O I
10.1016/j.ijcard.2012.11.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To examine the prevalence of peripheral artery disease (PAD) and the relationship between PAD and cardiovascular (CV) outcomes in subjects with left ventricular systolic dysfunction, heart failure or both after acute myocardial infarction (MI). Background: PAD is associated with poorer prognosis in patients with stable and unstable coronary heart disease but whether PAD is associated with worse outcomes following substantial acute MI is unknown. Methods: Univariate and multivariate Cox proportional hazards modelling was used to compare clinical outcomes in an individual-patient meta-analysis of 4 trials (CAPRICORN, EPHESUS, OPTIMAAL and VALIANT). Results: Of the 28,771 patients randomized, 2357 (8.2%) had PAD. These patients were older and had more co-morbidity and were less likely to be prescribed aspirin or a beta-blocker compared to patients without PAD. Over a mean follow-up of 2.7 years, 5121 (17.8%) patients died and 15,055 (52.3%) experienced CV death or hospitalization. PAD was an independent predictor of all individual and composite CV outcomes examined (including heart failure), with the exception of stroke. In patients with PAD (compared to those without PAD), the adjusted hazard ratio (HR) for all-cause mortality was 1.25 (95% CI 1.15-1.37; p<0.001) and the HR for CV death, non-fatal MI, non-fatal stroke or heart failure hospitalization was 1.24 (1.16-1.33; p<0.001). Conclusions: PAD is common and is an independent predictor of worse outcomes in patients already at high risk after MI because of left ventricular systolic dysfunction, heart failure or both. These patients represent an important group for intensive application of secondary preventive therapies. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1094 / 1101
页数:8
相关论文
共 24 条
[1]   Peripheral arterial disease and Virchow's triad [J].
Bennett, Philip C. ;
Silverman, Stanley H. ;
Gill, Paramjit S. ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (06) :1032-1040
[2]   Prevalence and prognostic influence of peripheral arterial disease in patients ≥40 years old admitted into hospital following an acute coronary event [J].
Bertomeu, V. ;
Morillas, P. ;
Gonzalez-Juanatey, J. R. ;
Quiles, J. ;
Guindo, J. ;
Soria, F. ;
Llacer, A. ;
Lekuona, I. ;
Mazon, P. ;
Martin-Luengo, C. ;
Rodriguez-Padial, L. .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (02) :189-196
[3]   Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes [J].
Bhatt, Deepak L. ;
Peterson, Eric D. ;
Harrington, Robert A. ;
Ou, Fang-Shu ;
Cannon, Christopher P. ;
Gibson, C. Michael ;
Kleiman, Neal S. ;
Brindis, Ralph G. ;
Peacock, W. Frank ;
Brener, Sorin J. ;
Menon, Venu ;
Smith, Sidney C., Jr. ;
Pollack, Charles V., Jr. ;
Gibler, W. Brian ;
Ohman, E. Magnus ;
Roe, Matthew T. .
EUROPEAN HEART JOURNAL, 2009, 30 (10) :1195-1202
[4]   Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization [J].
Chiu, JH ;
Topol, EJ ;
Whitlow, PL ;
Hsu, AP ;
Tuzcu, EM ;
Franco, I ;
Moliterno, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :582-583
[5]   Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study [J].
Cotter, G ;
Cannon, CP ;
McCabe, CH ;
Michowitz, Y ;
Kaluski, E ;
Charlesworth, A ;
Milo, O ;
Bentley, J ;
Blatt, A ;
Krakover, R ;
Zimlichman, R ;
Reisin, L ;
Marmor, A ;
Lewis, B ;
Vered, Z ;
Caspi, A ;
Braunwald, E .
AMERICAN HEART JOURNAL, 2003, 145 (04) :622-627
[6]   Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].
Dargie, HJ ;
Colucci, Y ;
Ford, I ;
Sendon, JLL ;
Remme, W ;
Sharpe, N ;
Blank, A ;
Holcslaw, TL .
LANCET, 2001, 357 (9266) :1385-1390
[7]   Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction [J].
Dargie, HJ .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (03) :325-332
[8]   Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[9]   Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction:: The OPTIMAAL trial design [J].
Dickstein, K ;
Kjekshus, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (04) :477-481
[10]   The High-Risk Myocardial Infarction Database Initiative [J].
Dickstein, Kenneth ;
Bebchuk, Judith ;
Wittes, Janet .
PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (04) :362-366